|
|
Article: AaiPharma acquires injectable treatment.
- Article from:
- BT Catalyst
- Article date:
- May 1, 2003
CopyrightCOPYRIGHT 2003 North Carolina Biotechnology Center. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
AaiPharma (Nasdaq: AAII) of Wilmington has acquired exclusive rights to an injectable methadone product from Roxane Laboratories Inc. of Columbus, Ohio.
AaiPharma plans to re-brand the pain product under a new trade name and launch it in the third quarter of this year.
The acquisition will ...
Related newspaper, magazine, and journal articles:
|
|
Article: aaiPharma Inc. Names President; - Dr. Philip Tabbiner Named ...
PR Newswire;
February 7, 2002 ;
700+ words
... ... pharmaceutical companies into new product opportunities. Through the Company's NeoSan Pharmaceuticals business unit, aaiPharma acquires, enhances, and markets branded drug products using proprietary drug delivery technologies and product life cycle ...
|
|